|
Market Closed -
Euronext Paris
19:55:00 19/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.10 EUR | 0.00% |
|
+0.26% | -36.96% |
| 09-17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 332M 364M 307M 278M 521M 33.99B 545M 3.71B 1.47B 18.37B 1.37B 1.34B 58.19B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 284M 311M 263M 238M 446M 29.09B 467M 3.18B 1.26B 15.72B 1.17B 1.14B 49.79B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
| BOIp | Real-time | ||
| BON | Delayed | ||
| 0DTF | Real-time | ||
| BON | Delayed | ||
| BON | Real-time |
| 1 week | +0.26% | ||
| Current month | +2.14% | ||
| 1 month | +5.23% | ||
| 3 months | -27.10% | ||
| 6 months | -28.73% | ||
| Current year | -36.96% |
| 1 week | 18.85 | 19.25 | |
| 1 month | 17.45 | 20.3 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 42.8 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 A | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 A | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 A | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.26% | -28.86% | -52.06% | 364M | ||
| -1.87% | -5.01% | +29.17% | +126.86% | 1,232B | ||
| -2.00% | -5.78% | +31.91% | +78.19% | 656B | ||
| -1.07% | -3.92% | +21.47% | +104.55% | 506B | ||
| -1.04% | -1.80% | +28.69% | +68.33% | 382B | ||
| -3.08% | -8.87% | +40.89% | +30.42% | 340B | ||
| -3.22% | -5.20% | +24.48% | +50.97% | 294B | ||
| -2.51% | -4.49% | -2.15% | +31.64% | 278B | ||
| -0.91% | -5.76% | +28.55% | +65.87% | 240B | ||
| -1.15% | -0.60% | +30.35% | +119.66% | 210B | ||
| Average | -1.66% | -2.15% | +20.45% | +62.44% | 414B | |
| Weighted average by Cap. | -1.84% | -2.67% | +27.16% | +87.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 535M 451M 408M 766M 49.98B 802M 5.46B 2.16B 27.01B 2.01B 1.97B 85.55B | 501M 550M 464M 420M 787M 51.37B 824M 5.61B 2.22B 27.76B 2.06B 2.02B 87.93B |
| Net income | 11.34M 12.44M 10.49M 9.49M 17.81M 1.16B 18.64M 127M 50.32M 628M 46.68M 45.7M 1.99B | 32.64M 35.83M 30.22M 27.33M 51.28M 3.35B 53.67M 365M 145M 1.81B 134M 132M 5.73B |
| Net Debt | -49.74M -54.59M -46.04M -41.65M -78.13M -5.1B -81.77M -557M -221M -2.76B -205M -201M -8.73B | -47.86M -52.52M -44.3M -40.07M -75.17M -4.91B -78.68M -535M -212M -2.65B -197M -193M -8.4B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | €19.10 | 0.00% | 258 |
| 18/11/26 | €19.10 | -0.78% | 649 |
| 17/11/26 | €19.25 | +1.32% | 1,291 |
| 16/11/26 | €19.00 | -1.04% | 1,591 |
| 13/11/26 | €19.20 | +0.79% | 1,710 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
















